.jpg)
.jpg)
.jpg)
Associate Director TxBDC
UT Dallas
Dr. Renanker is a Neural Engineer who has dedicated his life to developing solutions to empower individuals with neurological injuries to realize their life’s goals.
Dr. Rennaker’s team has raised over $40M in the past 7 years to develop technologies and therapies to treat neurological injuries. The team has participated in 5 clinical trials over the past 7 years. The team has published over 150 peer reviewed publications, using custom closed-loop preclinical rehabilitations developed by the team. All preclinical and clinical studies are preregistered. The team has designed, developed, and currently manufactures a miniature, wireless class 3 implantable stimulator to enable the delivery of Targeted Plasticity Therapy. The team has also developed an array of technologies that can communicate with the implantable stimulator to deliver motor, sensory and cognitive rehabilitation.
Dr. Rennaker is a US Marine Veteran who served in Operation Sharp Edge, Desert Shield/Storm, and Provide comfort from 1988-1993 and was awarded multiple accommodations for his service including the Navy Achievement Medal during Desert Storm. Dr. Rennaker served as the founding director of the Texas Biomedical Device Center from 2012 – 2019, and Department Chair for the Biomedical Engineering Department at UT Dallas from 2013-2019. Dr. Rennaker is currently serving as a Professor in Neuroscience and Bioengineering at UT Dallas. Dr. Rennaker currently has positions with Konan Medical USA, Teliatry Inc., Optokinetix Inc. and several start-ups.
Conflict of Interest:
Dr. Rennaker is the inventor of the EyeKinetix technologies which has been commercialized by Konan Medical USA.
Dr. Rennaker is an employee of Konan Medical USA.
Dr. Rennaker is the inventor of the ReStore Vagus Nerve Stimulator which has been commercialized by Teliatry Inc. Dr. Rennaker is President and minority shareholder in Teliatry Inc.
Dr. Rennaker is a share holder of X-Nerve.
Tuesday, September 28, 2021
11:10 AM – 12:25 PM ET
